Skip to Content

Monomethyl fumarate Side Effects

Applies to monomethyl fumarate: oral delayed release capsule

Hematologic

Common (1% to 10%): Lymphopenia[Ref]

Hypersensitivity

Frequency not reported: Anaphylaxis, angioedema[Ref]

Immunologic

Frequency not reported: Herpes zoster, disseminated herpes zoster, herpes zoster ophthalmicus, herpes zoster meningoencephalitis, herpes zoster meningomyelitis, herpes simplex virus, West Nile virus, cytomegalovirus, Candida, Aspergillus, Nocardia, Listeria monocytogenes, Mycobacterium tuberculosis)[Ref]

Genitourinary

Common (1% to 10%): Albumin urine present[Ref]

Hepatic

Common (1% to 10%): Aspartate aminotransferase increased

Frequency not reported: Liver injury[Ref]

Nervous system

Frequency not reported: Progressive Multifocal Leukoencephalopathy (PML)[Ref]

Cardiovascular

Very common (10% or more): Flushing (40%)[Ref]

Dermatologic

Common (1% to 10%): Pruritus, rash, erythema[Ref]

Gastrointestinal

Very common (10% or more): Abdominal pain (18%), diarrhea (14%), nausea (12%)

Common (1% to 10%): Vomiting, dyspepsia[Ref]

References

1. "Product Information. Retevmo (selpercatinib)." Lilly, Eli and Company, Indianapolis, IN.

Frequently asked questions

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.